Login
Navigate Fool.com
Will IBB beat
the market?
Community Rating: 3 Stars: Appealing

222.73 5.12 (2.35%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $220.34
Previous Close $217.61
Daily Range $217.43 - $223.14
52-Week Range $163.41 - $275.40
Market Cap $4.7B
P/E Ratio -946.13
Dividend (Yield) $0.29 (0.0%)
Ex-Dividend Date
Dividend Pay Date
06/27/13
07/03/13
Volume 4,587,305
Average Daily Volume 3,369,840
Current FY EPS $0.00

How do you think IBB
will perform against the market?

Top IBB Bull/Bear Pitches

 

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches here!

 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary Rss Feed

Biotech Bubble Bust: 2 Ways to Win

Why Gilead and Biogen are the best ways to play the biotech meltdown.

Biotech: Where the Rubber Meets the Road

High-quality biotech stocks may be forming a durable bottom.

Google Earnings Are All About the Core

Traders should watch for volatility around Google's report.

US Markets Take Another Wild Ride, With Utilities, Transports, and Financials on the Upswing

Today's financial recap and tomorrow's financial outlook.

Eight Serious Market Indicators to Watch During This Correction

Are Biotechs Bad Medicine for the S&P 500?

Are biotechs to blame for the recent downturn in the S&P 500?

3 Biotech Stocks Falling Like a Knife: Puma Biotechnology, MacroGenics, and Aratana Therapeutics

Last week's three worst performing biotech stocks.

Is a Correction in the Charts for Health Care Stocks?

Higher relative returns have a way of making investors think the trees can grow a bit taller or, failing that, the sky can be lowered. But market history illustrates the danger of such a mindset.

Is a Relative-Performance Correction in the Charts for Health Care Stocks?

Higher relative returns have a way of making investors think the trees can grow a bit taller or, failing that, the sky can be lowered. But market history illustrates the danger of such a mindset.

Why You Should Still Be Considering A Bio-Tech Stock, But With A Sensible Hedge

See More IBB News...

Sector

Financials

Industry

Financial Services

iShares NASDAQ Biotechnology Index (ETF) (IBB) Description

The investment seeks investment results that correspond generally to the price and yield performance before fees and expenses of the NASDAQ Biotechnology Index (the underlying index). Website: http://www.ishares.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks